Nausea Medicine Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


Nausea is a condition usually associated with motion sickness, dizziness, and vomiting. Nausea medicines are used to treat symptoms of nausea and prevent vomiting. Common classes of nausea medicines include antihistamines, anticholinergics, phenothiazines, cannabinoids, and 5-HT3 receptor antagonists. Antihistamines like dimenhydrinate and meclizine are over-the-counter medicines commonly used for nausea relief. Prescription nausea medicines include ondansetron, granisetron, and dolasetron which work by blocking serotonin receptors in the body. The growing prevalence of conditions that cause nausea like migraine, chemotherapy, pregnancy, and gastrointestinal disorders is increasing the demand for effective nausea treatments.

The global Nausea Medicine Market is estimated to be valued at US$ 2.8 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends in the nausea medicine market is the increased research and development of novel drug formulations and drug delivery methods. For instance, companies are developing transdermal patches, sublingual tablets, and orally disintegrating tablets to overcome challenges associated with oral drugs like delayed onset of action and unpredictable absorption. Transdermal patches provide sustained delivery of antiemetics and help avoid the gastrointestinal route. Sublingual tablets and orally dissolving formulations dissolve rapidly in the mouth enabling faster absorption and relief from nausea. Another important trend is the focus on developing highly selective serotonin 5-HT3 receptor antagonists and neurokinin-1 receptor antagonists with improved side effect profiles compared to existing therapies. Constant innovations aimed at enhancing efficacy, safety, and patient compliance are expected to boost the nausea medicine market growth over the forecast period.

Porter's Analysis

Threat of new entrants: Low due to high capital requirement in R&D and regulations.

Bargaining power of buyers: High due to availability of alternative treatments.

Bargaining power of suppliers: Moderate due to availability of substitutes and regulations.

Threat of new substitutes: Moderate threat from generic drugs, herbal and over-the-counter treatments.

Competitive rivalry: Intense competition among existing pharmaceutical companies.

Key Takeaways

The global Nausea Medicine Market is expected to witness high growth. The global Nausea Medicine Market is estimated to be valued at US$ 2.8 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030.

Regional analysis related content comprises the North America region currently dominates the market and is expected to retain its position throughout the forecast period due to advanced healthcare infrastructure and presence of major players. Asia Pacific is expected to witness fastest growth due to rising healthcare expenditure and growing awareness.

Key players operating in the Nausea Medicine market are GlaxoSmithKline plc., Pfizer Inc., Novartis International AG, Sanofi S.A., Merck & Co., Inc., Johnson & Johnson, Bayer AG, Takeda Pharmaceutical Company Limited, AstraZeneca plc., and Eli Lilly and Company. GlaxoSmithKline plc holds the leading market share in the nausea medicine market owing to its effective drugs and strong distribution networks worldwide. Takeda Pharmaceutical Company and Sanofi S.A are also among the top players due to presence across regions and robust product portfolio.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

Breast Pumps Market to Surpass US$ 1,211.6 Million with a CAGR of 4.6% by 2027

-
Image
A breast pump is a mechanical tool used by breastfeeding women to suction-extract their breast milk, which they then use to feed their newborn children. Both manually and electrically driven breast pumping equipment is available. Breast pumps are advantageous for working women, women with shorter gestational periods, and women who give birth to multiples since they are unable to simultaneously breastfeed all of the babies, therefore they prefer a breast pump. Breast pumps aid in meeting the nutritional needs of babies of working mothers who do not want to sacrifice their development and growth since they are not constantly present with their infants. Business Dynamics Launches of breast pumps by leading industry players are anticipated to fuel the market's expansion throughout the forecast period. For instance, Sonata, the first smart breast pump to give hospital-level performance in a personal use breast pump, was introduced by Madela, Inc. in November 2016. This breast pump conn...
Read more

Angioedema Treatment Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2024 To 2031

-
Image
Introduction: Angioedema, a condition characterized by rapid swelling of deeper layers of the skin and mucous membranes, poses a significant health concern for affected individuals. The Angioedema Treatment Market has been witnessing notable advancements, providing a ray of hope for patients grappling with this often unpredictable and potentially life-threatening condition. Market Dynamics: The Angioedema Treatment Market has experienced a paradigm shift in recent years, driven by increased awareness, improved diagnostic capabilities, and a surge in research and development efforts. Angioedema can be hereditary or acquired, and the market is witnessing a growing prevalence of both forms, necessitating a diversified approach to treatment options. Treatment Modalities: Therapeutic approaches to Angioedema have evolved, offering a range of options for patients. Antihistamines and corticosteroids are commonly prescribed for acute cases, providing relief from swelling and discomfort. In mor...
Read more